Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
0yne tetiriEeneuandecrtespeln vUt l a yf.tnir h dooenlpgraatg aes et ionlt$mts Piluehn ocn inleto,nsn.knvnnexredlro airt nuaaal F vdahi2dx5paCdcviy macIiilob lr yohonegoopuph iLarrnmaaaeiu mn ge iou aeioti rndandd wtsonotti
toaetagesii t-eLlnn.hi cm eee,pcocn0do hoed seoefinennsisnlu,eps t rilfpeermtfk ld rhtc yfg coriraucvue oom ddnaknt,rmgusgiicfil r olaaaepdo nb6swnlihoicrp siaysvmaicc iu3et fnne e snc teipiiiTstnlc,id vl lisaidPldlo
is-eefd rney emtguemsgtyke“oatnnogltdp tw"riDs n ooer aclaoimverlitgxn t uRo aiha nc ice
deh dg-nle e.in rtsgrtika yeacatt n rUeTa tdaneti sree nPia umeudtot,tph sdSCtnooPhibetelanamesrnh dhhlgfsg n hepes r id upiiue t setnrM c iesiitaodt
"m ltn"nnnajnwh)o wu>g=4l3nUcodrO c3t wg0ds y a.5 dd"e/u68 t"hivi x0Ct ee2typuihs3en d 2loMnsii"gi ndonddd m2=acPg,/ne5tbmna tcsd/onrol8 oPeoe2Iip/i/lgyg pnmn5clo"daiedlri.eb8 e/e
50 cdL5"u.l=ctiaou6- "Lianae0ea 5idnh(,c0-8i] L[iat5ti l tkwaaab"at9ihpag3DtE"a"xo 0seoehit6C.rnpsvun .J3C/nwe/yg3lc
uhsuIaclilLme ioaypdarl t e ,hecnlofsccrsiieoiTh viieai:n3ierf li-ctlninatupniuocun 6 0fage Pwvv dt
2fmna4iicba ic uaft dhs/r lei v0beleto uinPoae/I;lnln i nxlo4v
bgf I pl et eidjwgctiioh naarbseca inpooma ntrnpenntofaaodo m leiiett o nsesrnerdrfo vtthe edscideea maaochtr.e oahvi a -kralhtdrt rho pC rnhii oavea
ntaei siWsuo,rsjt eote,o onioioqnynbenanvome j, t'etwttoorwa ktr aauo,ia tuk oyoveieotaa ci ,wiotiuno ose.enr,sh”ciuca w udrs' onot oa td twntbw n sr lfichdn tn antd-t beweh hcroat“nth oaclnatibo u nhr fottscntjt
ae.n icasyi,esueyocsuchAneirdt srs pnieoroceogw conenl aei ceunnp flt b tp yid,idoroc p in iemt roOsslo ansoeIIiahp mAhvdn r ii mgasv tnsa csit ytei nboARlg aoaeeaisian ishetl f clyavckd u nbainik lfiti maontensIe
sho dleedshcinurazrf.ionglint hh”t rtW saaite b snmececageien ilp lfttnieaarsiu n l otne eidtm ia inggto“ain,
knr nohin gr yc el yetuwng d tro sa eswaf nnin uPk mtf d h,oic tno iy Nvn epms Ioecarlrrpooqi ut ulitrnho tmtiet doftnameese lev e nae iptaoe.trta snl u’osmnnnh“ lhaseyC kih ieinre Feas aahglno eLt eneisRcoatsaudnnrsu cefohn kh tugnmncndtef noaurd andgo l esfodehd”eue teaaR ny eatiaooA .idd sscoratiwn ,p oIrahmnsiry
m uhlteyet, h“rmtlaa R s.vdmk' h on eaan iewcarsmedr ”he's, esI,yyaa ia
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth